These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6525445)

  • 21. Plasma protein binding of phenyl in dogs and rats as determined by equilibrium dialysis and ultrafiltration.
    Liao TF; Oehme FW
    Toxicol Appl Pharmacol; 1981 Feb; 57(2):226-30. PubMed ID: 7222039
    [No Abstract]   [Full Text] [Related]  

  • 22. Displacement of lidocaine from human plasma proteins by disopyramide.
    Bonde J; Jensen NM; Burgaard P; Angelo HR; Graudal N; Kampmann JP; Pedersen LE
    Pharmacol Toxicol; 1987 Feb; 60(2):151-5. PubMed ID: 3575249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on plasma protein binding of carbamazepine.
    Di Salle E; Pacifici GM; Morselli PL
    Pharmacol Res Commun; 1974 Apr; 6(2):193-202. PubMed ID: 4474672
    [No Abstract]   [Full Text] [Related]  

  • 24. Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
    Bombardt PA; Brewer JE; Johnson MG
    J Pharmacol Exp Ther; 1994 Apr; 269(1):145-50. PubMed ID: 8169818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Binding of the reticuloendotheliotropic vital dye-stuffs lithium carmine and trypan blue to plasma proteins].
    Gestewitz HR; Wulf E
    Acta Histochem; 1973; 46(1):18-37. PubMed ID: 4210093
    [No Abstract]   [Full Text] [Related]  

  • 26. Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep.
    Rutten AJ; Mather LE; Plummer JL; Henning EC
    J Pharm Pharmacol; 1992 Apr; 44(4):355-8. PubMed ID: 1355550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
    Belpaire FM; De Rick A; Bourda A; De Smet F; Rosseel MT; Bogaert MG
    J Pharm Pharmacol; 1990 Jan; 42(1):45-9. PubMed ID: 1969949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing serum protein binding of lidocaine in humans.
    McNamara PJ; Slaughter RL; Pieper JA; Wyman MG; Lalka D
    Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of changes in arterial CO2 tension on plasma lidocaine concentration.
    Alexander CM; Berko RS; Gross JB; Kagle DM; Shaw LM
    Can J Anaesth; 1987 Jul; 34(4):343-5. PubMed ID: 3111736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide.
    Rohatagi S; Luo Y; Shen L; Guo Z; Schemm C; Huang Y; Chen K; David M; Nave R; King SP
    Am J Ther; 2005; 12(3):201-9. PubMed ID: 15891262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.
    Hinderling PH; Bres J; Garrett ER
    J Pharm Sci; 1974 Nov; 63(11):1684-90. PubMed ID: 4427225
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions of apomorphine with serum and tissue proteins.
    Smith RV; Velagapudi RB; McLean AM; Wilcox RE
    J Med Chem; 1985 May; 28(5):613-20. PubMed ID: 3989821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of lactic acid on the serum protein binding of bupivacaine: species differences.
    Coyle DE; Denson DD; Thompson GA; Myers JA; Arthur GR; Bridenbaugh PO
    Anesthesiology; 1984 Aug; 61(2):127-33. PubMed ID: 6431850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophobic interactions responsible for unspecific binding of morphine-like drugs.
    Höllt V; Teschemacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):163-77. PubMed ID: 240130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazepam and lidocaine plasma protein binding in renal disease.
    Grossman SH; Davis D; Kitchell BB; Shand DG; Routledge PA
    Clin Pharmacol Ther; 1982 Mar; 31(3):350-7. PubMed ID: 7037263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the toxicology of carbromal. IV. Binding of carbromal and its hypnotically active metabolites to human plasma proteins (author's transl)].
    Vohland HW; Streichert B
    Arch Toxicol; 1978 Oct; 41(1):69-77. PubMed ID: 31154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of cephalosporins with human and canine serum proteins.
    Peterson LR; Gerding DN
    J Infect Dis; 1978 Apr; 137(4):452-7. PubMed ID: 649989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P
    Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum protein binding of AL01576, a new aldose reductase inhibitor.
    McNamara PJ; Blouin RA; Brazzell RK
    Pharm Res; 1988 May; 5(5):319-21. PubMed ID: 3149737
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro binding of amantadine to plasma proteins.
    Liu P; Cheng PJ; Ing TS; Daugirdas JT; Jeevanandhan R; Soung LS; Galinis S
    Clin Neuropharmacol; 1984; 7(2):149-51. PubMed ID: 6733694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.